Paradigm Capital Management (Nevada)’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.03M Sell
8,306
-150
-2% -$34.9K 1.86% 17
2025
Q4
$1.75M Sell
8,456
-49
-0.6% -$9.69K 1.63% 18
2025
Q3
$1.58M Sell
8,505
-1,100
-11% -$188K 1.56% 20
2025
Q2
$1.47M Sell
9,605
-360
-4% -$55.3K 1.45% 20
2025
Q1
$1.65M Sell
9,965
-590
-6% -$92.3K 1.69% 17
2024
Q4
$1.53M Buy
10,555
+125
+1% +$19.4K 1.43% 21
2024
Q3
$1.69M Buy
+10,430
New +$1.66M 1.62% 18
2022
Q4
$1.78M Sell
10,092
-10
-0.1% -$1.73K 2.61% 10
2022
Q3
$1.65M Sell
10,102
-200
-2% -$33.8K 2.2% 11
2022
Q2
$1.83M Sell
10,302
-100
-1% -$17.8K 2.3% 10
2022
Q1
$1.84M Sell
10,402
-10
-0.1% -$1.7K 1.86% 14
2021
Q4
$1.78M Buy
+10,412
New +$1.7M 1.77% 15

Other funds holding JNJ

Paradigm Capital Management (Nevada)'s JNJ Position: Q1 2026 in Review

Paradigm Capital Management (Nevada) reduced its Johnson & Johnson (JNJ) stake by 1.8% in Q1 2026, selling an estimated $34.9K and leaving 8,306 shares worth $2.03M. The position accounts for 1.86% of the portfolio, ranked #17.

Paradigm Capital Management (Nevada) first reported a position in JNJ in Q4 2021 and has held it in 12 quarters since. 4,618 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Paradigm Capital Management (Nevada) held 8,306 shares of Johnson & Johnson worth $2.03M as of Q1 2026.
  • Paradigm Capital Management (Nevada) sold 150 Johnson & Johnson shares in Q1 2026, an estimated $34.9K.
  • Johnson & Johnson made up 1.86% of Paradigm Capital Management (Nevada)'s portfolio in Q1 2026, its #17 holding.
  • Paradigm Capital Management (Nevada) first reported a position in Johnson & Johnson in Q4 2021 and has held it in 12 quarters since.
  • 4,618 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Paradigm Capital Management (Nevada)'s 13F filing for Q1 2026, filed 6 May 2026.